Cargando…

Epigenetics of prostate cancer: beyond DNA methylation

Epigenetic mechanisms permit the stable inheritance of cellular properties without changes in DNA sequence or amount. In prostate carcinoma, epigenetic mechanisms are essential for development and progression, complementing, amplifying and diversifying genetic alterations. DNA hypermethylation affec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schulz, W A, Hatina, J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2006
Materias:	Invited Review-Epigenetic Review Series
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3933104/ https://www.ncbi.nlm.nih.gov/pubmed/16563224 http://dx.doi.org/10.1111/j.1582-4934.2006.tb00293.x

Ejemplares similares

X-linked mental retardation and epigenetics
por: Froyen, Guy, et al.
Publicado: (2006)

Epigenetic boundaries of tumour suppressor gene promoters: the CTCF connection and its role in carcinogenesis
por: Recillas-Targa, Felix, et al.
Publicado: (2006)

Prostate cancer epigenetics and its clinical implications
por: Yegnasubramanian, Srinivasan
Publicado: (2016)

The DNA methylation landscape in cancer
por: Skvortsova, Ksenia, et al.
Publicado: (2019)

Epigenetic regulation of prostate cancer: the theories and the clinical implications
por: Liao, Yiji, et al.
Publicado: (2019)

Epigenetics, DNA damage, and aging
por: Soto-Palma, Carolina, et al.
Publicado: (2022)

Research progress of m(6)A methylation in prostate cancer
por: Zhang, Shou-Yi, et al.
Publicado: (2022)

Genome-wide DNA methylation analysis of patients with imprinting disorders identifies differentially methylated regions associated with novel candidate imprinted genes
por: Docherty, Louise E, et al.
Publicado: (2014)

DNA alterations in the tumor genome and their associations with clinical outcome in prostate cancer
por: Liu, Wennuan
Publicado: (2016)

Cell-specific epigenetic changes in atherosclerosis
por: Khan, Abdul Waheed, et al.
Publicado: (2021)

Metabolic Signaling to Epigenetic Alterations in Cancer
por: Kim, Jung-Ae, et al.
Publicado: (2018)

Conflicts Targeting Epigenetic Systems and Their Resolution by Cell Death: Novel Concepts for Methyl-Specific and Other Restriction Systems
por: Ishikawa, Ken, et al.
Publicado: (2010)

Cell-type deconvolution from DNA methylation: a review of recent applications
por: Titus, Alexander J., et al.
Publicado: (2017)

Mice with targeted disruption of spermidine/spermine N(1)-acetyltransferase gene maintain nearly normal tissue polyamine homeostasis but show signs of insulin resistance upon aging
por: Niiranen, Kirsi, et al.
Publicado: (2006)

α - synuclein and Parkinson’s disease: the first roadblock
por: Lin Chua, Christelle En, et al.
Publicado: (2006)

Immunohistochemical evaluation of phosphorylated SMAD2/SMAD3 and the co-activator P300 in human glomerulonephritis: correlation with renal injury
por: Kassimatis, Theodoros I, et al.
Publicado: (2006)

Epigenetics in psychiatry: Beyond DNA methylation
por: Kouter, Katarina, et al.
Publicado: (2023)

Diversity and dynamics of DNA methylation: epigenomic resources and tools for crop breeding
por: Kawakatsu, Taiji, et al.
Publicado: (2019)

Personalized strategies in population screening for prostate cancer
por: Remmers, Sebastiaan, et al.
Publicado: (2020)

Histone deacetylase 10, a potential epigenetic target for therapy
por: Cheng, Fajuan, et al.
Publicado: (2021)

DNA Methylation Biomarkers: Cancer and Beyond
por: Mikeska, Thomas, et al.
Publicado: (2014)

Epigenetic mechanisms in Tendon Ageing
por: Riasat, Kiran, et al.
Publicado: (2020)

The complexity of epigenetic diseases
por: Brazel, Ailbhe Jane, et al.
Publicado: (2015)

The RISK pathway and beyond
por: Rossello, Xavier, et al.
Publicado: (2017)

Spatial, temporal and interindividual epigenetic variation of functionally important DNA methylation patterns
por: Schneider, Eberhard, et al.
Publicado: (2010)

Monoclonal antibodies targeting CD38 in hematological malignancies and beyond
por: van de Donk, Niels W. C. J., et al.
Publicado: (2016)

Prostate cancer stem cells
por: Lang, SH, et al.
Publicado: (2009)

Role of chemotherapy in prostate cancer
por: Nader, Rita, et al.
Publicado: (2018)

Vitamin D in prostate cancer
por: Trump, Donald L, et al.
Publicado: (2018)

Hormone naïve prostate cancer: predicting and maximizing response intervals
por: Moul, Judd W
Publicado: (2015)

Perspectives on the clinical development of immunotherapy in prostate cancer
por: Cordes, Lisa M, et al.
Publicado: (2018)

Glucocorticoids and prostate cancer treatment: friend or foe?
por: Montgomery, Bruce, et al.
Publicado: (2014)

Multiple therapeutic and preventive effects of 3,3′-diindolylmethane on cancers including prostate cancer and high grade prostatic intraepithelial neoplasia
por: Zhang, William Weiben, et al.
Publicado: (2014)

Epigenetics and Chromatin Remodeling in Adult Cardiomyopathy
por: Mahmoud, Salma Awad, et al.
Publicado: (2013)

Epigenetics of pregnancy: looking beyond the DNA code
por: Zuccarello, Daniela, et al.
Publicado: (2022)

Beyond the snapshot: optimizing prognostication and prediction by moving from fixed to functional multidimensional cancer pathology
por: Kramer, CJH, et al.
Publicado: (2022)

Prostate-associated gene 4 (PAGE4), an intrinsically disordered cancer/testis antigen, is a novel therapeutic target for prostate cancer
por: Kulkarni, Prakash, et al.
Publicado: (2016)

Multiparametric Magnetic Resonance Imaging for Active Surveillance of Prostate Cancer
por: An, Julie Y., et al.
Publicado: (2017)

The role of mRNA splicing in prostate cancer
por: Lapuk, Anna V, et al.
Publicado: (2014)

Current early diagnostic biomarkers of prostate cancer
por: Qu, Min, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_gmmg92eonp4vc8c4077j0obbnt